Bioprinted Cancer Microenvironment Model with Segmented Cell Zones
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer models fail to accurately mimic in vivo cancer microenvironments, particularly in terms of complexity and heterogeneity, and are often time- and cost-inefficient to produce.
Innovation Solution
A construct comprising cancer cells, cancer stem cells, and cancer-associated fibroblasts, along with supportive, specialized, immune, and endothelial cells, combined with an extracellular matrix, is used to create a bioprinted model that mimics the in vivo cancer microenvironment, allowing for rapid and cost-effective drug testing and preclinical studies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional 2D and 3D cell cultures are used to create cancer models, then the models are simple to produce, but they fail to accurately mimic the complexity and heterogeneity of in vivo cancer microenvironments
Solution Approach 1:
The cancer microenvironment is segmented into distinct functional zones with different cell type compositions. The construct includes a core region with cancer stem cells and cancer cells, surrounded by intermediate zones with cancer-associated fibroblasts and immune cells, and an outer region with endothelial cells and supportive cells. This spatial segmentation allows each zone to contribute specific functions while collectively creating a realistic microenvironment that improves mimicking accuracy without requiring the entire construct to be uniformly complex.
Solution Approach 2:
Different regions of the construct are assigned different local qualities through selective cell type distribution. The core region has high cell density with cancer stem cells and cancer cells for studying tumorigenesis, while the outer regions have supportive cells and endothelial cells for studying tumor-stroma interactions and angiogenesis. This local differentiation enables the construct to simultaneously represent multiple aspects of the in vivo microenvironment with appropriate spatial heterogeneity.
2Reliability
If complex multi-cell type constructs are created to accurately represent cancer microenvironments, then the model reliability improves, but the time required to prepare the constructs increases
Solution Approach 1:
Cells are pre-sorted into distinct populations and pre-cultured in optimized conditions before construct assembly. Cancer stem cells, cancer cells, cancer-associated fibroblasts, immune cells, and endothelial cells are each prepared in advance with appropriate growth factors and maturation protocols. This preliminary preparation allows the actual construct assembly to proceed efficiently without delays, as all cell components are ready for immediate integration into the final multi-cell type construct.
Solution Approach 2:
The construct uses a standardized modular architecture that can be repeatedly assembled using the same protocol. Once the optimal composition and arrangement of different cell types is established, this design serves as a template that can be copied and reproduced multiple times. This standardization enables rapid replication of complex multi-cell type constructs without requiring re-optimization for each new construct, significantly reducing preparation time while maintaining representativeness.
3Reliability
If traditional cancer models are used, then the production cost is lower, but the models lack the heterogeneity and complexity of real tumor microenvironments
Solution Approach 1:
The construct employs a universal platform design that can model multiple types of cancer microenvironments by simply changing the cell type composition ratios and spatial arrangement, rather than developing entirely separate models for each cancer type. The same base construct architecture with its multi-zone structure can represent breast cancer, lung cancer, colorectal cancer, and other tumor types by adjusting which cell types are included and in what proportions. This multi-functionality reduces the overall manufacturing cost across different cancer model applications.
Solution Approach 2:
The construct achieves cancer heterogeneity representation through parameter changes in cell type ratios, spatial distribution patterns, and extracellular matrix composition rather than through fundamentally different construction approaches. By varying parameters such as the percentage of cancer stem cells versus cancer cells, or the density of immune cells in different zones, the same basic construct design can represent different cancer types and microenvironment conditions. This parameter-based customization is more cost-effective than developing entirely new models for each cancer type.
4Productivity
If rapid construct preparation is implemented to reduce time loss, then productivity improves, but the quality and biological maturity of the model may be compromised
Solution Approach 1:
The construct incorporates self-organizing properties where cells automatically arrange themselves into appropriate spatial configurations and establish functional interactions after assembly. The pre-sorted cell populations and optimized extracellular matrix composition enable cells to self-organize into the desired multi-zone structure without requiring complex post-assembly manipulation or extended maturation periods. This self-service capability allows rapid construct preparation while maintaining biological maturity, as the cells naturally progress through their developmental stages once placed in the appropriate microenvironment.
Data Source
AI summary
The present disclosure relates to constructs, and particularly bioprinted constructs, that are able to mimic an in vivo environment, such a cancer microenvironment. The disclosure also extends to methods and kits for making such constructs. The constructs may find particular application as models for drug development, drug screening and/or clinical evaluation of a drug product.